Exploring diagnosis and treatment of premenstrual dysphoric disorder in the U.S. healthcare system: a qualitative investigation

BACKGROUND: Premenstrual Dysphoric Disorder (PMDD) is a premenstrual condition that affects 3–8% of the US population, yet knowledge on treatment and consistent diagnostic testing is lacking. While research concerning the epidemiology and pharmaceutical treatments for this condition has increased, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Kiera, Rubtsova, Anna A., Clark, Cari Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193729/
https://www.ncbi.nlm.nih.gov/pubmed/37198676
http://dx.doi.org/10.1186/s12905-023-02334-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193729/
https://www.ncbi.nlm.nih.gov/pubmed/37198676
http://dx.doi.org/10.1186/s12905-023-02334-y

Ejemplares similares